David S. Wang, MD

Interventional radiologist, Radiologist, Minimally invasive surgeon, Diagnostic radiologist

Clinical Associate Professor, Radiology

View Professional Summary

Additional Languages Spoken:

Mandarin

Insurance Coverage

Resources for Referring Physicians

Professional Summary

Education & Certifications

Board Certification: American Board of Radiology, Interventional Radiology (2017)
Medical Education: Stanford University School of Medicine (2005) CA
Internship: Scripps Mercy Hospital San Diego (2006) CA
- Residency: Stanford University Radiology Residency (2010) CA
- Fellowship: University of Pennsylvania Health System (2011) PA
- BA & BS, Stanford University, Economics & Biological Sciences (1999)

View More Education & Certifications

Memberships

Associate Member, Stanford Cancer Institute (2015 - Present)
Member, Stanford Bio-X (2014 - Present)

Publications

Mechanotransduction of endothelial oxidative stress induced by cyclic strain
Wang, D. S., Proffit, D., & Tsao, P. S. (2001). Mechanotransduction of endothelial oxidative stress induced by cyclic strain. ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH, 8(4), 283–291.
NOS inhibition accelerates atherogenesis: reversal by exercise
Niebauer, J., Maxwell, A. J., Lin, P. S., Wang, D., Tsao, P. S., & Cooke, J. P. (2003). NOS inhibition accelerates atherogenesis: reversal by exercise. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 285(2), H535–H540.
Airway management after maxillectomy: Routine tracheostomy is unnecessary
Lin, H. S., Wang, D., Fee, W. E., Goode, R. L., & Terris, D. J. (2003). Airway management after maxillectomy: Routine tracheostomy is unnecessary. LARYNGOSCOPE. INDIANAPOLIS,IN,IN,IN,IN,IN,IN: LIPPINCOTT WILLIAMS & WILKINS.
- In-stent restenosis limitation with stent-based controlled-release nitric oxide: Initial results in rabbits
  Do, Y. S., Kao, E. Y., Ganaha, F., Minamiguchi, H., Sugimoto, K., Lee, J., … Dake, M. D. (2004). In-stent restenosis limitation with stent-based controlled-release nitric oxide: Initial results in rabbits. RADIOLOGY, 230(2), 377–82.
- Local resistance to oxidative stress by overexpression of copper-zinc superoxide dismutase limits neointimal formation after angioplasty
  Kuo, M. D., Bright, I. J., Wang, D. S., Ghafouri, P., Yuksel, E., Hilfiker, P. R., … Dake, M. D. (2004). Local resistance to oxidative stress by overexpression of copper-zinc superoxide dismutase limits neointimal formation after angioplasty. JOURNAL OF ENDOVASCULAR THERAPY, 11(6), 585–94.
- Endovascular repair of abdominal and thoracic aortic aneurysms
  Katzen, B. T., Dake, M. D., MaClean, A. A., & Wang, D. S. (2005). Endovascular repair of abdominal and thoracic aortic aneurysms. CIRCULATION, 112(11), 1663–75.
- Directed migration of smooth muscle cells to engineer plaque-resistant vein grafts
  Amabile, P. G., Wang, D. S., Kao, E. Y., Lee, J., Elkins, C. J., Yuksel, E., … Dake, M. D. (2005). Directed migration of smooth muscle cells to engineer plaque-resistant vein grafts. JOURNAL OF ENDOVASCULAR THERAPY, 12(6), 667–75.
- Will stent-graft repair emerge as treatment of choice for acute type B dissection?
  Dake, M. D., & Wang, D. S. (2006). Will stent-graft repair emerge as treatment of choice for acute type B dissection? SEMINARS IN VASCULAR SURGERY, 19(1), 40–47.
- Molecular imaging: A primer for interventionalists and imagers
  Wang, D. S., Dake, M. D., Park, J. M., & Kuo, M. D. (2006). Molecular imaging: A primer for interventionalists and imagers. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 17(9), 1405–23.
- Comparative evaluation of noninvasive compression adjuncts for hemostasis in percutaneous arterial, venous, and arteriovenous dialysis access procedures
  Wang, D. S., Chu, L. F., Olson, S. E., Miller, F. J., Valji, K., Wong, W. H., … Kuo, M. D. (2008). Comparative evaluation of noninvasive compression adjuncts for hemostasis in percutaneous arterial, venous, and arteriovenous dialysis access procedures. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 19(1), 72–79.
- Monitoring of the biological response to murine Hindlimb ischemia with Cu-64-labeled vascular endothelial growth factor-121 positron emission tomography
  Willmann, J. K., Chen, K., Wang, H., Paulmurugan, R., Rollins, M., Cai, W., … Gambhir, S. S. (2008). Monitoring of the biological response to murine Hindlimb ischemia with Cu-64-labeled vascular endothelial growth factor-121 positron emission tomography. CIRCULATION, 117(7), 915–22.
- Identification of noninvasive imaging surrogates for brain tumor gene-expression modules
  Diehn, M., Nardini, C., Wang, D. S., McGovern, S., Jayaraman, M., Liang, Y., … Kuo, M. D. (2008). Identification of noninvasive imaging surrogates for brain tumor gene-expression modules. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 105(13), 5213–18.
- Molecular Imaging: A Primer for Interventionalists and Imagers (Reprinted from J Vasc Interv Radiol, vol 17, pg 1405-1423, 2006)
  Wang, D. S., Dake, M. D., Park, J. M., & Kuo, M. D. (2009). Molecular Imaging: A Primer for Interventionalists and Imagers (Reprinted from J Vasc Interv Radiol, vol 17, pg 1405-1423, 2006). JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 20(7), S505–S522.
- Cationic versus Neutral Microbubbles for Ultrasound-mediated Gene Delivery in Cancer
  Wang, D. S., Panje, C., Pysz, M. A., Paulmurugan, R., Rosenberg, J., Gambhir, S. S., … Willmann, J. K. (2012). Cationic versus Neutral Microbubbles for Ultrasound-mediated Gene Delivery in Cancer. RADIOLOGY, 264(3), 721–32.
- Heparin-induced thrombocytopenia (HIT) causing portosplenic, superior mesenteric, and splenic vein thrombosis resulting in splenic rupture and pulmonary emboli formation
  Lammering, J. C., Wang, D. S., & Shin, L. K. (2012). Heparin-induced thrombocytopenia (HIT) causing portosplenic, superior mesenteric, and splenic vein thrombosis resulting in splenic rupture and pulmonary emboli formation. CLINICAL IMAGING, 36(6), 865–68.
- Ultrasound-Mediated Gene Delivery with Cationic Versus Neutral Microbubbles: Effect of DNA and Microbubble Dose on In Vivo Transfection Efficiency
  Panje, C. M., Wang, D. S., Pysz, M. A., Paulmurugan, R., Ren, Y., Tranquart, F., … Willmann, J. K. (2012). Ultrasound-Mediated Gene Delivery with Cationic Versus Neutral Microbubbles: Effect of DNA and Microbubble Dose on In Vivo Transfection Efficiency. THERANOSTICS, 2(11), 1078–91.
- Prophylactic Topically Applied Ice to Prevent Cutaneous Complications of Nontarget Chemoembolization and Radioembolization
  Wang, D. S., Louie, J. D., Kothary, N., Shah, R. P., & Sze, D. Y. (2013). Prophylactic Topically Applied Ice to Prevent Cutaneous Complications of Nontarget Chemoembolization and Radioembolization. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 24(4), 596–600.
- Correlation between global gene expression patterns and magnetic resonance imaging findings in glioblastoma multiforme
  Wang, D. S., Cha, S., Nardini, C., Diehn, M., Chan, B. K., & Kuo, M. D. (2004). Correlation between global gene expression patterns and magnetic resonance imaging findings in glioblastoma multiforme. NEURO-ONCOLOGY, 6(4), 340–340.
- Neuroimaging characteristics reflect tumor gene expression signatures and predict survival in glioblastoma multiforme
  Diehn, M., Nardini, C., Wang, D. S., Hsiao, A., Cha, S., & Kuo, M. D. (2006). Neuroimaging characteristics reflect tumor gene expression signatures and predict survival in glioblastoma multiforme. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 66(3), S18–S18.
- Noninvasive imaging of hypoxia-inducible factor-1a gene therapy for myocardial ischemia.
  Chen, I. Y., Gheysens, O., Li, Z., Rasooly, J. A., Wang, Q., Paulmurugan, R., … Gambhir, S. S. (2013). Noninvasive imaging of hypoxia-inducible factor-1a gene therapy for myocardial ischemia. Human Gene Therapy Methods, 24(5), 279–88.
- Ultrasound and microbubble-mediated gene delivery in cancer: progress and perspectives.
  Panje, C. M., Wang, D. S., & Willmann, J. K. (2013). Ultrasound and microbubble-mediated gene delivery in cancer: progress and perspectives. Investigative Radiology, 48(11), 755–69.
- A titratable two-step transcriptional amplification strategy for targeted gene therapy based on ligand-induced intramolecular folding of a mutant human estrogen receptor.
  Chen, I. Y., Paulmurugan, R., Nielsen, C. H., Wang, D. S., Chow, V., Robbins, R. C., & Gambhir, S. S. (2014). A titratable two-step transcriptional amplification strategy for targeted gene therapy based on ligand-induced intramolecular folding of a mutant human estrogen receptor. Molecular Imaging and Biology , 16(2), 224–34.
- Intra-arterial therapies for metastatic colorectal cancer.
  Wang, D. S., Louie, J. D., & Sze, D. Y. (2013). Intra-arterial therapies for metastatic colorectal cancer. Seminars in Interventional Radiology, 30(1), 12–20.
- Stent-grafts for thoracic aortic aneurysms and dissections.
  Wang, D. S., & Dake, M. D. (2010). Stent-grafts for thoracic aortic aneurysms and dissections. Handbook of Vascular & Interventional Radiologic Procedures. Lippincott Williams & Wilkins.
- Endovascular treatment for type B aortic dissection.
  Wang, D. S., & Dake, M. D. (2006). Endovascular treatment for type B aortic dissection. Trends in Vascular Surgery. Greenwood Academic.
- Endovascular stent-grafts for treatment of thoracic aortic diseases.
  Wang, D. S., & Dake, M. D. (2005). Endovascular stent-grafts for treatment of thoracic aortic diseases. Abrams’ Angiography: Interventional Radiology. Little, Brown and Company.
- Translating nanotechnology to vascular disease.
  Kuo, M. D., Waugh, J. M., Elkins, C. J., & Wang, D. S. (2004). Translating nanotechnology to vascular disease. Nanoscale Technology in Biomedical Systems. CRC Press.
- A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinoma.
  Banerjee, S., Wang, D. S., Kim, H. J., Sirlin, C. B., Chan, M. G., Korn, R. L., … Kuo, M. D. (2015). A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinoma. Hepatology , 62(3), 792–800.
- Local Stent-Based Release of Transforming Growth Factor-1 Limits Arterial In-Stent Restenosis
  Wang, D. S., Ganaha, F., Kao, E. Y., Lee, J., Elkins, C. J., Waugh, J. M., & Dake, M. D. (2016). Local Stent-Based Release of Transforming Growth Factor-1 Limits Arterial In-Stent Restenosis. JALA, 21(2), 305–11.
- Endovascular Stent Placement for May-Thurner Syndrome in the Absence of Acute Deep Vein Thrombosis.
  Ahmed, O., Ng, J., Patel, M., Ward, T. J., Wang, D. S., Shah, R., & Hofmann, L. V. (2016). Endovascular Stent Placement for May-Thurner Syndrome in the Absence of Acute Deep Vein Thrombosis. Journal of Vascular and Interventional Radiology , 27(2), 167–73.
- Ultrasound-guided therapeutic modulation of hepatocellular carcinoma using complementary microRNAs.
  Mullick Chowdhury, S., Wang, T.-Y., Bachawal, S., Devulapally, R., Choe, J. W., Abou Elkacem, L., … Willmann, J. K. (2016). Ultrasound-guided therapeutic modulation of hepatocellular carcinoma using complementary microRNAs. Journal of Controlled Release , 238, 272–80.
- Endovascular treatment for type B aortic dissection.
  Wang, D. S., & Dake, M. D. (2010). Endovascular treatment for type B aortic dissection. Modern Trends in Vascular Surgery: Surgery of the Aorta & its Body Branches. People’s Medical Publishing House.
- Transcatheter Therapy for Hepatic Malignancy: Standardization of Terminology and Reporting Criteria.
  Gaba, R. C., Lewandowski, R. J., Hickey, R., Baerlocher, M. O., Cohen, E. I., Dariushnia, S. R., … Brown, D. B. (2016). Transcatheter Therapy for Hepatic Malignancy: Standardization of Terminology and Reporting Criteria. Journal of Vascular and Interventional Radiology , 27(4), 457–73.
- Yttrium-90 Radioembolization for Unresectable Combined Hepatocellular-Cholangiocarcinoma.
  Chan, L. S., Sze, D. Y., Poultsides, G. A., Louie, J. D., Abdelrazek Mohammed, M. A., & Wang, D. S. (2017). Yttrium-90 Radioembolization for Unresectable Combined Hepatocellular-Cholangiocarcinoma. Cardiovascular and Interventional Radiology.
- Authors' Reply: Letter to the Editor Regarding "Yttrium-90 Radioembolization for Unresectable Combined Hepatocellular-Cholangiocarcinoma".
  Wang, D. S., & Sze, D. Y. (2017). Authors' Reply: Letter to the Editor Regarding "Yttrium-90 Radioembolization for Unresectable Combined Hepatocellular-Cholangiocarcinoma". Cardiovascular and Interventional Radiology.
- Quantitative Emphysema Score as a Predictor of Morbidity in Transthoracic Needle Aspiration Biopsy
  Gonzales, N., Wang, D., Holty, J.-E., Kuschner, W., Raffy, P., Laeseke, P., … Van Wert, R. (2015). Quantitative Emphysema Score as a Predictor of Morbidity in Transthoracic Needle Aspiration Biopsy. CHEST. AMER COLL CHEST PHYSICIANS.
- Phase II study of epacadostat with pembrolizumab in metastatic or unresectable gastroesophageal junction and gastric adenocarcinoma requiring paired biopsies.
  Kardosh, A., Tseng, D., Sahaf, B., Zomet, A., Krupa, J., Fisher, G. A., … Kunz, P. L. (2018). Phase II study of epacadostat with pembrolizumab in metastatic or unresectable gastroesophageal junction and gastric adenocarcinoma requiring paired biopsies. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.
- Local Stent-Based Release of Transforming Growth Factor-ß1 Limits Arterial In-Stent Restenosis.
  Wang, D. S., Ganaha, F., Kao, E. Y., Lee, J., Elkins, C. J., Waugh, J. M., & Dake, M. D. (2016). Local Stent-Based Release of Transforming Growth Factor-ß1 Limits Arterial In-Stent Restenosis. Journal of Laboratory Automation, 21(2), 305–11.
- Albumin-Bilirubin Score: An Accurate Predictor of Hepatic Decompensation in High-Risk Patients Undergoing Transarterial Chemoembolization for Hepatocellular Carcinoma
  Mohammed, M. A. A. R., Khalaf, M. H., Liang, T., Wang, D. S., Lungren, M. P., Rosenberg, J., & Kothary, N. (2018). Albumin-Bilirubin Score: An Accurate Predictor of Hepatic Decompensation in High-Risk Patients Undergoing Transarterial Chemoembolization for Hepatocellular Carcinoma. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 29(11), 1527–34.
- A Role for Virtual Reality in Planning Endovascular Procedures
  Mohammed, M. A. A., Khalaf, M. H., Kesselman, A., Wang, D. S., & Kothary, N. (2018). A Role for Virtual Reality in Planning Endovascular Procedures. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 29(7), 971–74.
- Evidence-Based Integration of Yttrium-90 Radioembolization in the Contemporary Management of Hepatic Metastases from Colorectal Cancer.
  Wang, D. S., Louie, J. D., & Sze, D. Y. (2019). Evidence-Based Integration of Yttrium-90 Radioembolization in the Contemporary Management of Hepatic Metastases from Colorectal Cancer. Techniques in Vascular and Interventional Radiology, 22(2), 74–80.
- Quantification of Activity Lost to Delivery-System Residual and Decay in Yttrium-90 Radioembolization
  Hoang, N. S., Khalaf, M. H., Rosenberg, J. K., Kwofie, J., Reposar, A. L., Wang, D. S., … Sze, D. Y. (2018). Quantification of Activity Lost to Delivery-System Residual and Decay in Yttrium-90 Radioembolization. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 29(12), 1672–77.
- Contemporary management of metastatic soft tissue sarcoma.
  Bui, N. Q., Wang, D. S., & Hiniker, S. M. (2019). Contemporary management of metastatic soft tissue sarcoma. Current Problems in Cancer.
- Lower Extremity Venous Stent Placement: A Large Retrospective Single-Center Analysis.
  Mabud, T. S., Cohn, D. M., Arendt, V. A., Jeon, G.-S., An, X., Fu, J., … Hofmann, L. V. (2019). Lower Extremity Venous Stent Placement: A Large Retrospective Single-Center Analysis. Journal of Vascular and Interventional Radiology : JVIR.
- Deep-Learning for Automated Classification of Inferior Vena Cava Filter Types on Radiographs.
  Ni, J. C., Shpanskaya, K., Han, M., Lee, E. H., Do, B. H., Kuo, W. T., … Wang, D. S. (2019). Deep-Learning for Automated Classification of Inferior Vena Cava Filter Types on Radiographs. Journal of Vascular and Interventional Radiology : JVIR.
- KRAS status and survival in multicenter study of RAS mutations (MURAS) in patients with colorectal liver metastases receiving Y90 radioembolization treatment
  Case, M. D., Ghodadra, A., Novelli, P. M., Wu, V., Ganguli, S., Wildgruber, M., … Kim, H. S. (2020). KRAS status and survival in multicenter study of RAS mutations (MURAS) in patients with colorectal liver metastases receiving Y90 radioembolization treatment. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.
- Genomic biomarkers to determine survival in Multicenter Study of RAS mutations (MURAS) in patients with colorectal liver metastases receiving Y90 radioembolization treatment.
  Case, M. D., Ghodadra, A., Novelli, P. M., Wu, V., Ganguli, S., Wildgruber, M., … Kim, K. (2020). Genomic biomarkers to determine survival in Multicenter Study of RAS mutations (MURAS) in patients with colorectal liver metastases receiving Y90 radioembolization treatment. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.
- ACR Appropriateness Criteria Nontraumatic Aortic Disease.
  Gunn, A. J., Kalva, S. P., Majdalany, B. S., Craft, J., Eldrup-Jorgensen, J., Ferencik, M., … Dill, K. E. (2021). ACR Appropriateness Criteria Nontraumatic Aortic Disease. Journal of the American College of Radiology : JACR, 18(5S), S106–S118.
- Safety and Feasibility of Cryoablation during Immunotherapy in Patients with Metastatic Soft Tissue Sarcoma.
  Doshi, A., Zhou, M., Bui, N., Wang, D. S., Ganjoo, K., & Hwang, G. L. (2021). Safety and Feasibility of Cryoablation during Immunotherapy in Patients with Metastatic Soft Tissue Sarcoma. Journal of Vascular and Interventional Radiology : JVIR.
- Consensus Guidelines for the Definition of Time-to-Event End Points in Image-guided Tumor Ablation: Results of the SIO and DATECAN Initiative.
  Puijk, R. S., Ahmed, M., Adam, A., Arai, Y., Arellano, R., de Baère, T., … Meijerink, M. R. (2021). Consensus Guidelines for the Definition of Time-to-Event End Points in Image-guided Tumor Ablation: Results of the SIO and DATECAN Initiative. Radiology, 203715.
- Efficacy and Safety of Trans-Arterial Yttrium-90 Radioembolization in Patients with Unresectable Liver-Dominant Metastatic or Primary Hepatic Soft Tissue Sarcomas.
  Testa, S., Bui, N. Q., Wang, D. S., Louie, J. D., Sze, D. Y., & Ganjoo, K. N. (2022). Efficacy and Safety of Trans-Arterial Yttrium-90 Radioembolization in Patients with Unresectable Liver-Dominant Metastatic or Primary Hepatic Soft Tissue Sarcomas. Cancers, 14(2).
- Multi-center validation of an artificial intelligence system for detection of COVID-19 on chest radiographs in symptomatic patients.
  Kuo, M. D., Chiu, K. W., Wang, D. S., Larici, A. R., Poplavskiy, D., Valentini, A., … Erickson, B. J. (2022). Multi-center validation of an artificial intelligence system for detection of COVID-19 on chest radiographs in symptomatic patients. European Radiology.
- Monitoring sarcoma response to immune checkpoint inhibition and local cryotherapy with circulating tumor DNA analysis.
  Bui, N. Q., Nemat-Gorgani, N., Subramanian, A., Torres, I. A., Lohman, M., Sears, T. J., … Moding, E. J. (2023). Monitoring sarcoma response to immune checkpoint inhibition and local cryotherapy with circulating tumor DNA analysis. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
- Automatic Detection of Perilunate and Lunate Dislocations on Wrist Radiographs Using Deep Learning.
  Pridgen, B., von Rabenau, L., Luan, A., Gu, A. J., Wang, D. S., Langlotz, C., … Do, B. (2023). Automatic Detection of Perilunate and Lunate Dislocations on Wrist Radiographs Using Deep Learning. Plastic and Reconstructive Surgery.
- ACR Appropriateness Criteria® Sudden Onset of Cold, Painful Leg: 2023 Update.
  Browne, W. F., Sung, J., Majdalany, B. S., Khaja, M. S., Calligaro, K., Contrella, B. N., … Steigner, M. L. (2023). ACR Appropriateness Criteria® Sudden Onset of Cold, Painful Leg: 2023 Update. Journal of the American College of Radiology : JACR, 20(11S), S565–S573.
- ACR Appropriateness Criteria® Pulsatile Abdominal Mass, Suspected Abdominal Aortic Aneurysm: 2023 Update.
  Wang, D. S., Shen, J., Majdalany, B. S., Khaja, M. S., Bhatti, S., Ferencik, M., … Steigner, M. L. (2023). ACR Appropriateness Criteria® Pulsatile Abdominal Mass, Suspected Abdominal Aortic Aneurysm: 2023 Update. Journal of the American College of Radiology : JACR, 20(11S), S513–S520.
- ACR Appropriateness Criteria® Chylothorax Treatment Planning: 2024 Update.
  Kokabi, N., Dabbous, H., Khaja, M. S., Baker, J. B., Brixey, A. G., Browne, W. F., … Majdalany, B. S. (2025). ACR Appropriateness Criteria® Chylothorax Treatment Planning: 2024 Update. Journal of the American College of Radiology : JACR, 22(5S), S177–S189.
- ACR-ABS-ACNM-ARS-SIR-SNMMI Practice Parameter for Radioembolization of Liver Malignancies.
  Johnson, T., Spieler, B. O., Toskich, B. B., Wang, D. S., Folkert, M. R., Russo, S., … Schechter, N. R. (2025). ACR-ABS-ACNM-ARS-SIR-SNMMI Practice Parameter for Radioembolization of Liver Malignancies. American Journal of Clinical Oncology.
- Preliminary Report: International Randomized Study of Transarterial Chemoembolization (TACE) versus Stereotactic Body Radiotherapy for Residual/Recurrent Hepatocellular Carcinoma After Initial TACE
  Hui, C., Hall, J., Kothary, N., Sze, D., Wang, D., Koong, A., … Chang, D. (2023). Preliminary Report: International Randomized Study of Transarterial Chemoembolization (TACE) versus Stereotactic Body Radiotherapy for Residual/Recurrent Hepatocellular Carcinoma After Initial TACE. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS. LIPPINCOTT WILLIAMS & WILKINS.
- ACR Appropriateness Criteria Abdominal Aortic Aneurysm or Dissection-Interventional Planning and Follow-Up: Update 2025.
  Sheeran, D. P., Tong, R. T., Khaja, M. S., Higgins, M. C., Kokabi, N., Charalel, R., … Majdalany, B. S. (2026). ACR Appropriateness Criteria Abdominal Aortic Aneurysm or Dissection-Interventional Planning and Follow-Up: Update 2025. Journal of the American College of Radiology : JACR.

View More Publications

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Open Trials Closed Trials

A Study Using [18F]F AraG PET to Evaluate Response to Checkpoint Inhibitor Therapy(CkIT) in Patients With Solid Tumors

Yttrium-90 (Y90) Glass Microspheres PET/CT in Imaging Patients With Liver Tumors

A Study of ABI-H2158-containing Regimens in Participants With Chronic Hepatitis B Virus Infection

Epacadostat and Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Junction or Gastric Cancer

Specializing In

Practice Locations

Interventional Radiology in Palo Alto Palo Alto, CA

Palo Alto, CA

Interventional Radiology in Palo Alto

875 Blake Wilbur Dr

Palo Alto , CA 94304

(650) 736-9081

More Clinic Information

Fibroid Center Palo Alto, CA

Palo Alto, CA

Fibroid Center

900 Blake Wilbur Dr, Fl 2

Palo Alto , CA 94304

(650) 497-9691

More Clinic Information

Hypertension Center Palo Alto, CA

Palo Alto, CA

Hypertension Center

300 Pasteur Dr, Fl 1 Ste A11

Palo Alto , CA 94305

(650) 723-6961

More Clinic Information

Imaging Services at Stanford Medicine Cancer Center Palo Alto, CA

Palo Alto, CA

Imaging Services at Stanford Medicine Cancer Center

875 Blake Wilbur Dr

Palo Alto , CA 94304

(650) 723-6855

More Clinic Information

Important Information about Our Organizations and Physician Affiliation

Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.

Patient Reviews

(39 reviews)

I felt very comfortable with Dr Wang

Sep 2025

•

Verified SHC Patient

I was extremely satisfied with Dr. Wang. He was thoughtful, informative and empathetic in our conversation. He explained everything that had to do with my situation and went over all options. I feel comfortable with his care.

Aug 2025

•

Verified SHC Patient

Doctor Wang was knowledgeable and helpful, patiently answering all my questions and concerns. I learned a lot and feel that I have an excellent path forward.

Mar 2025

•

Verified SHC Patient

Dr. Wang is a very knowledgeable doctor and skilled practitioner.

Mar 2025

•

Verified SHC Patient

Dr Wang is excellent and knows his business. He makes the patient feel very comfortable, even during a stressful procedure. He has an excellent bedside manner and approaches you friendly, honest and truthful.

Mar 2025

•

Verified SHC Patient

Excellent and thorough along with excellent bedside manner and sense of humor.

Oct 2024

•

Verified SHC Patient

Excellent surgeon who explains things very well.

Jul 2024

•

Verified SHC Patient

Dr. Wang presented a lot of information; he was thorough about discussing the procedures and the possible side effects. Because he had a mandatory meeting to attend, we were unable to ask as many questions as we wanted.

May 2024

•

Verified SHC Patient

Dr. Wang was great. He fully explained the procedure, and possibilities of outcome.

Apr 2024

•

Verified SHC Patient

Excellent and detailed explanation of what to expect, both for the procedure and time spent at clinic.

Feb 2024

•

Verified SHC Patient

He and his PA were able to answer all my questions and some that I didnâ€™t even know to ask. It was so very informative and I appreciate both of them giving me all their honest thoughts and information. They both made me feel so much better about moving forward with the upcoming procedure

Dec 2023

•

Verified SHC Patient

Dr. Wang is exceptional! In 2 conversations with him he helped me truly understand my options, answered ALL my questions and made me feel assured in my options. Heâ€™s is kind and specific without being intimidating in his delivery. I am VERY GRATEFUL for him. THANK YOU Dr. WANG!!!

Dec 2023

•

Verified SHC Patient

Great man thorough

Oct 2023

•

Verified SHC Patient

It was a very knowledgeable visit. He answered all my questions.

Oct 2023

•

Verified SHC Patient

Professional, knowledgeable, caring, and patient. I have confidence in his skills to do my UFE.

Sep 2023

•

Verified SHC Patient

He made it easy to understand the details of my ct scan, which I appreciated. On top of his expertise in this field, I loved the genuine concerns and care he had for my condition. Most importantly he feels approachable . Medical professionals almost always feel intimidating! Cheers!

Jul 2023

•

Verified SHC Patient

Dr. Wang is a very good Doctor especially when it comes to explaining your condition and the procedure.

Jun 2023

•

Verified SHC Patient

Excellent Doctor.

Jun 2023

•

Verified SHC Patient

Dr. Wang is very personal, thorough, knowledgeable, and clear.

Jun 2023

•

Verified SHC Patient

David explains very well about my incoming treatment.

Mar 2023

•

Verified SHC Patient

Very good doctor very professional and very caring

Feb 2023

•

Verified SHC Patient

I love talking to Dr. Wang. He is very professional. He seems extremely concerned about your procedure. He makes you feel at ease.

Feb 2023

•

Verified SHC Patient

Really like him and the care I received from him

Feb 2023

•

Verified SHC Patient

David Wang was superb. He displayed great knowledge of my situation and of his abilities. He was very professional and personable, he had a definite plan of action which he explained very clearly, he was very solicitous of Mik owing my thoughts and concerns as well as whether I understood his plan and goal and the risks involved. After meeting with Dr. Wang, I feel that I am in excellent and trustworthy hands.

Dec 2022

•

Verified SHC Patient

Superior doctor and a good communicator.

Dec 2022

•

Verified SHC Patient

Dr. David Wang was awesome. He explained everything to me in great detail. He showed me pictures of my cat scan, and explained to me what I was seeing. He demonstrated how the procedure would happen. He explained the risks in the procedure. From our video visit and conversation he just went above and beyond with making sure I understand everything concerning my kidney mass.

Nov 2022

•

Verified SHC Patient

An excellent doctor who provided all the information I needed to know.

Nov 2022

•

Verified SHC Patient

Our conversation with Dr. Wang was the first real information we have received about our diagnosis, so it was greatly appreciated. While being realistic about the prognosis, he kept it hopeful.

Jul 2022

•

Verified SHC Patient

He is the best doctor and nice person thank you so much for help me

Jun 2022

•

Verified SHC Patient

Informative and thorough.

May 2022

•

Verified SHC Patient

Excellent professional and human being!!!

May 2022

•

Verified SHC Patient

Excellent surgeon who cares about his patients.

Feb 2022

•

Verified SHC Patient

Dr Wang is a true gift. To me, to the Stanford community and to the world. He has the rare combination of knowledge, compassion, and a willingness to try new ideas. I recommend him without reservation.

Dec 2021

•

Verified SHC Patient

Excellent surgeon and Excellent at explaining things.

Nov 2021

•

Verified SHC Patient

Looking forward to meeting him in person and hoping he does procedure as I am nervous.

Oct 2021

•

Verified SHC Patient

Excellent physician, thorough, focused, inspiring confidence his personal touch suffused the visit (despite the depersonalizing interface)

May 2021

•

Verified SHC Patient

Excellent at getting background info, explaining and listening. I didn't feel rushed at all and felt like a partner in the decision-making process. Thank you, Dr. Wang

May 2021

•

Verified SHC Patient

Very thorough. Very personable.

May 2021

•

Verified SHC Patient

Oops....I did that in the previous comment section about the video appointment. Sorry. But I did cover both these areas. in my previous comment. Dr. David Wang, in my opinion, is just awesome and I am so lucky to have him as one of my most important physicians handling my care.

Apr 2021

•

Verified SHC Patient

View More Patient Reviews

Referring Physicians

PHYSICIAN HELPLINE

Phone: 1-866-742-4811
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.

Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.

You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.

Send referrals online
Place radiology and lab orders
View referral status
Access medical records

Learn More About MedLink

LOG INTO MEDLINK

Adrenal Vein Sampling

Balloon angioplasty

Balloon Dilation

Cancer

Cancer Pain

Celiac Nerve Block

Central Venous Access Catheters

Chemical Ablation

Chemoembolization

Chronic Liver Disease

Core biopsy

Cryoablation for Arrhythmia

Deep Vein Thrombosis (DVT)

Dialysis Access

End of Life Care

Endovascular Stent Graft

Fallopian Tube Recanalization

Feeding Tube

Fine-needle aspiration biopsy

Gastrostomy (Feeding) Tube

Hepatitis

Intravascular Ultrasound (IVUS)

Kidney Failure

Lymph node biopsy

Lymphangiogram

Microwave Ablation

Needle biopsy

Percutaneous Ablation

Percutaneous Thrombectomy

Percutaneous Transluminal Angioplasty of the Femoral Artery

PTA of the Femoral Artery

Pulmonary Embolectomy

Pulmonary Embolism

Radioembolization

Radiofrequency Ablation

Renal Hypertension

Renal Vascular Disease

Spinal Compression Fractures

Targeted Therapy

Thrombolytic Therapy

Tumor Ablation Therapies

Ultrasound Fine Needle Aspiration Biopsy

Uterine Fibroid Embolization

Uterine Fibroids

Varicocele

Varicose Veins

Vascular Disease

Vena Cava Filter

Venogram

Wire Localization for Surgery

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

David S. Wang, MD

Interventional radiologist, Radiologist, Minimally invasive surgeon, Diagnostic radiologist

Get In Touch

Professional Summary

Education & Certifications

Memberships

Publications

Clinical Trials

Specializing In

Practice Locations

Interventional Radiology in Palo Alto Palo Alto, CA

Interventional Radiology in Palo Alto

Fibroid Center Palo Alto, CA

Fibroid Center

Hypertension Center Palo Alto, CA

Hypertension Center

Imaging Services at Stanford Medicine Cancer Center Palo Alto, CA

Imaging Services at Stanford Medicine Cancer Center

Important Information about Our Organizations and Physician Affiliation

Patient Reviews

(39 reviews)

Referring Physicians

PHYSICIAN HELPLINE

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

WELCOME BACK

David S. Wang, MD

Interventional radiologist, Radiologist, Minimally invasive surgeon, Diagnostic radiologist

Get In Touch

Professional Summary

Education & Certifications

Memberships

Publications

Clinical Trials

Specializing In

Practice Locations

Interventional Radiology in Palo Alto Palo Alto, CA

Interventional Radiology in Palo Alto

Fibroid Center Palo Alto, CA

Fibroid Center

Hypertension Center Palo Alto, CA

Hypertension Center

Imaging Services at Stanford Medicine Cancer Center Palo Alto, CA

Imaging Services at Stanford Medicine Cancer Center

Important Information about Our Organizations and Physician Affiliation

Patient Reviews

(39 reviews)

Referring Physicians

PHYSICIAN HELPLINE